Neurovascular function in Alzheimer's disease patients and experimental models. - Test2 - elhamkhani - TriplyDB

Neurovascular function in Alzheimer's disease patients and experimental models.

Neurovascular function in Alzheimer's disease patients and experimental models.

http://www.wikidata.org/entity/Q35088223

about

Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and Interventions HDL and glucose metabolism: current evidence and therapeutic potential Developmental switch in neurovascular coupling in the immature rodent barrel cortex Pathophysiology of the neurovascular unit: disease cause or consequence?Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology Neurochemical changes within human early blind occipital cortex.Coupling mechanism and significance of the BOLD signal: a status report.Advances in MRI biomarkers for the diagnosis of Alzheimer's disease.Early neurovascular dysfunction in a transgenic rat model of Alzheimer's disease.Model-based physiomarkers of cerebral hemodynamics in patients with mild cognitive impairment.Using genetics to enable studies on the prevention of Alzheimer's disease Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease.Effect of alpha-7 nicotinic acetylcholine receptor activation on beta-amyloid induced recognition memory impairment. Possible role of neurovascular function.Resveratrol treatment rescues neurovascular coupling in aged mice: role of improved cerebromicrovascular endothelial function and downregulation of NADPH oxidase.Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer's disease mice.Increased cerebral vascular reactivity in the tau expressing rTg4510 mouse: evidence against the role of tau pathology to impair vascular health in Alzheimer's disease Peroxisome proliferator-activated receptor γ controls ingestive behavior, agouti-related protein, and neuropeptide Y mRNA in the arcuate hypothalamus.A neurovascular perspective for long-term changes after brain trauma.Comparison of stimulus-evoked cerebral hemodynamics in the awake mouse and under a novel anesthetic regime.Enhanced penetration of exogenous EPCs into brains of APP/PS1 transgenic mice.Low Residual CBF Variability in Alzheimer's Disease after Correction for CO(2) Effect.Cerebrovascular function in aging and dementia: a systematic review of transcranial Doppler studies.Retinal microvascular network attenuation in Alzheimer's disease Oxidative stress affects processing of amyloid precursor protein in vascular endothelial cells Heparan sulfate proteoglycans mediate Aβ-induced oxidative stress and hypercontractility in cultured vascular smooth muscle cells Early brain injury alters the blood-brain barrier phenotype in parallel with β-amyloid and cognitive changes in adulthood Neurovascular coupling in humans: Physiology, methodological advances and clinical implications.Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.Endothelial TRPV4 channels mediate dilation of cerebral arteries: impairment and recovery in cerebrovascular pathologies related to Alzheimer's disease Glial Cell Calcium Signaling Mediates Capillary Regulation of Blood Flow in the Retina.Vasculo-Neuronal Coupling: Retrograde Vascular Communication to Brain Neurons.Sugar for the brain: the role of glucose in physiological and pathological brain function Comparison of Model-Based Indices of Cerebral Autoregulation and Vasomotor Reactivity Using Transcranial Doppler versus Near-Infrared Spectroscopy in Patients with Amnestic Mild Cognitive Impairment.Endothelial nitric oxide: protector of a healthy mind.Model-based quantification of cerebral hemodynamics as a physiomarker for Alzheimer's disease?Oxidation as "the stress of life".Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.Overlapped metabolic and therapeutic links between Alzheimer and diabetes.Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease.The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseases

P2860

Q26781557-4A9BF69B-BBD5-4D54-85A7-DA3B0AD2A59E Q26996502-055D449E-7475-49C8-86BA-9FAEA08A32CE Q27301750-0969E99E-B331-4B0A-BEA6-7ADE1464C7BF Q27690845-B4C7E1D3-38B3-4401-871B-66E319D029DD Q28594423-B5054B54-51AD-4A18-852F-A2A690AE0B63 Q30408825-ABD6660B-5012-45B6-BAC8-84F7F4F0B1EA Q30836886-1785DE4C-8A61-4FAF-9C29-9F0E63A9F7A1 Q30870223-C79E9440-2E77-491E-9B46-84BA0F93A041 Q33555571-46B02C7C-B1D0-41A2-9FA0-8F22D2D7BDE2 Q33825909-06129365-824E-4561-B807-6D3F65C4A610 Q34038890-869CF76B-4C45-47DF-8417-A38F59F5B103 Q34277495-49FC3090-0216-4EF1-9D60-CDBE8F8379E5 Q34504497-546E0F66-B7DC-4D02-8AE6-F561A9AC73D4 Q34658269-42317583-1267-4BA6-88D5-82EF6357ABD9 Q34704978-52CF1575-5031-4A51-946D-2F93B5C34EDB Q35143533-35016F81-D8E1-4D5C-A261-30147CC52601 Q35187442-D2663AFE-F9E1-4E6A-8B2B-9C7F6331D2C4 Q35763336-CB62D119-D9A5-4F57-8778-D74B58CAA53E Q35896262-45666ECF-B5FE-40E5-9DE1-D01C5529C57F Q36019557-60CB8AE5-A36F-46C0-B2E3-0CB9F6BBF091 Q36076183-706F1D4C-0EE7-4D89-85A9-EAAFB6AE9804 Q36100626-7C1961A9-A6DE-4354-B420-F47A69A8B431 Q36237609-41384369-53F1-4EB7-A33C-B19EBD096D7C Q36406229-71525426-1723-4E86-9A69-62080E745BDF Q36489864-6DEFB6E2-6D0C-4980-94A5-B391CDA7AAE9 Q36587065-913FD0EF-F213-4833-8FFF-C446FD94A7CE Q36765857-C741D871-33C8-48A6-A4DB-1CC980862D20 Q37216153-2BB74330-5703-4C0F-B1BA-0C91E098E0A0 Q37219109-B645F959-7878-42C7-892B-C424708BD237 Q37236001-61D709B7-B184-472B-BE42-133FA90C82EF Q37504975-71966751-3339-41FB-B550-3775C286A46B Q37511476-6060411B-5A26-4137-B9EF-3C12DD9397EA Q37589714-36EB3661-2E8B-4697-BDE7-1EB252DF884B Q37687314-43B721A3-F13F-432F-850A-D7009952F0B4 Q37712238-85742578-95FF-48A3-BC3F-0CB2A36F1C38 Q37938589-E3BE5675-51E7-4988-87E7-2DA2927B19B5 Q37971834-EF51B578-2C9D-4DBE-85BC-8E58FDB0D9E5 Q38046539-96637D8F-797A-4BF1-AE93-B2E74B81C331 Q38067323-69A4AED6-3221-4297-B162-42D27CE9CA1E Q38157892-03BE2803-7A15-4462-9397-2804AF6EF0CB

P2860

Neurovascular function in Alzheimer's disease patients and experimental models.

http://www.wikidata.org/entity/Q35088223

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Neurovascular function in Alzheimer's disease patients and experimental models.

@ast

Neurovascular function in Alzheimer's disease patients and experimental models.

@en

type

label

Neurovascular function in Alzheimer's disease patients and experimental models.

@ast

Neurovascular function in Alzheimer's disease patients and experimental models.

@en

prefLabel

Neurovascular function in Alzheimer's disease patients and experimental models.

@ast

Neurovascular function in Alzheimer's disease patients and experimental models.

@en

P1433

Q35088223-370825D6-979B-4777-B89B-140D9A124A01

P1476

Q35088223-5F698F6E-5160-4305-B571-94287635FA04

P2093

Q35088223-3ED63AFC-05F5-47A5-B10A-1E6C93FCFCC9

Q35088223-A7712449-3C0B-4C8A-BF98-A7D1AC6FDE3A

P2860

Q35088223-00483FFC-E420-44C6-B4D9-AA7D0BE5AAD4

Q35088223-039F071E-147E-4852-BF29-524B1F8F2929

Q35088223-045C6696-1D6E-4DA1-8DF9-19D3AF9A93CE

Q35088223-0469EB20-6B29-4E28-8EBA-A058A255AA63

Q35088223-04AAEAF7-BAAA-4E31-A8D2-77E1D60673C7

Q35088223-04FE3380-D4A3-40ED-ADB5-9A8E30D6BD96

Q35088223-080E032B-C630-4309-920A-3719FEC915F2

Q35088223-0A5A2584-01F3-4C79-A104-1A174A9EE0D6

Q35088223-0AF35DF0-F70C-4326-A689-C0123FF93955

Q35088223-0D311BBB-1CF9-4DDB-88FC-E1F4C4F3C51C

P304

Q35088223-BC266F02-D7D1-4B7C-B314-9CD7CB6BFB52

P31

Q35088223-631587C8-CA0E-4B67-8E0C-9D401294FF69

P356

Q35088223-884D7499-B16E-41E4-9179-970C266E54BF

P433

Q35088223-DD6DA7F1-D0E8-405C-B136-B7519ADC0E0E

P478

Q35088223-955A979D-1997-4EFE-972B-0FE5B6AC575A

P577

Q35088223-1B2A4052-B927-4C7C-8CDF-3EE0E9986733

P698

Q35088223-06369558-84D9-48E7-8F54-F8C54815FFEB

P921

Q35088223-9BFE40F0-16C3-4DF3-A977-CC00E2A2B21E

P932

Q35088223-BC42B262-F519-49E7-8AEF-168AA72EDA7C

P356

P1433

Journal of Cerebral Blood Flow & Metabolism

P1476

Neurovascular function in Alzheimer's disease patients and experimental models.

@en

P2093

Edith Hamel

http://www.w3.org/2001/XMLSchema#string

Nektaria Nicolakakis

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Alzheimer's Disease

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Cholinesterase inhibitors for Alzheimer's disease

Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype.

A default mode of brain function

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study

Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised

Impaired cross-modal inhibition in Alzheimer disease

P304

1354-1370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JCBFM.2011.43

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21468088

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3130325

http://www.w3.org/2001/XMLSchema#string